Related Experiment Video
Updated: Jan 20, 2026
The Evidence for Evolution and Common Ancestor
Evidence-Based Prevention of Preeclampsia: Commonly Asked Questions in Clinical Practice
Dagmar Wertaschnigg1,2, Maya Reddy1,3, Ben W J Mol1,3
1Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
Abstract:
In this review, we discuss the recent literature regarding the prevention of preeclampsia and aim to answer common questions that arise in the routine antenatal care of pregnant women. Prescription of low-dose aspirin for high-risk patients has been shown to reduce the risk of preeclampsia (PE). A daily dose between 100 and 150 mg taken in the evening should be initiated prior to 16 weeks of gestation and can be continued until delivery. Calcium supplementation seems to be advantageous but currently it is only considered for patients with poor dietary intake and high risk for PE. Recent data about heparin are still conflicting, and therefore, heparin can currently not be recommended in the prevention of PE.
Related Concept Videos
The Evidence for Evolution
07:50Establishment of a Clinic-based Biorepository
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
08:55A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Common Ion Effect
08:16X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models

